Free Trial
NYSEAMERICAN:VNRX

VolitionRX (VNRX) Stock Price, News & Analysis

VolitionRX logo
$0.69 +0.03 (+5.12%)
As of 08/29/2025 04:10 PM Eastern

About VolitionRX Stock (NYSEAMERICAN:VNRX)

Key Stats

Today's Range
$0.64
$0.69
50-Day Range
$0.62
$0.87
52-Week Range
$0.40
$0.94
Volume
104,343 shs
Average Volume
181,558 shs
Market Capitalization
$74.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

VolitionRX Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

VNRX MarketRank™: 

VolitionRX scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for VolitionRX.

  • Earnings Growth

    Earnings for VolitionRX are expected to grow in the coming year, from ($0.50) to ($0.33) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of VolitionRX is -2.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of VolitionRX is -2.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about VolitionRX's valuation and earnings.
  • Percentage of Shares Shorted

    0.20% of the float of VolitionRX has been sold short.
  • Short Interest Ratio / Days to Cover

    VolitionRX has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in VolitionRX has recently decreased by 47.92%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    VolitionRX does not currently pay a dividend.

  • Dividend Growth

    VolitionRX does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.20% of the float of VolitionRX has been sold short.
  • Short Interest Ratio / Days to Cover

    VolitionRX has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in VolitionRX has recently decreased by 47.92%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    VolitionRX has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.11 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for VolitionRX this week, compared to 0 articles on an average week.
  • Search Interest

    6 people have searched for VNRX on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, VolitionRX insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.40% of the stock of VolitionRX is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 8.09% of the stock of VolitionRX is held by institutions.

  • Read more about VolitionRX's insider trading history.
Receive VNRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VolitionRX and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VNRX Stock News Headlines

Q2 2025 VolitionRX Ltd Earnings Call Transcript
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.tc pixel
Q1 2025 VolitionRX Ltd Earnings Call Transcript
See More Headlines

VNRX Stock Analysis - Frequently Asked Questions

VolitionRX's stock was trading at $0.58 at the beginning of 2025. Since then, VNRX shares have increased by 19.0% and is now trading at $0.69.

VolitionRX Limited (NYSEAMERICAN:VNRX) announced its quarterly earnings data on Wednesday, November, 10th. The medical research company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by $0.02. The medical research company had revenue of $0.03 million for the quarter, compared to the consensus estimate of $0.03 million.

Shares of VNRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that VolitionRX investors own include Chesapeake Energy (CHKAQ), Bausch Health Cos (BHC), Avino Silver & Gold Mines (ASM), Exelixis (EXEL), T2 Biosystems (TTOO), Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX).

Company Calendar

Last Earnings
11/10/2021
Today
9/01/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:VNRX
Previous Symbol
NYSEMKT:VNRX
CIK
93314
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.97 million
Net Margins
-1,766.89%
Pretax Margin
-1,781.59%
Return on Equity
N/A
Return on Assets
-234.05%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.35
Quick Ratio
0.35

Sales & Book Value

Annual Sales
$1.23 million
Price / Sales
60.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.28) per share
Price / Book
-2.46

Miscellaneous

Outstanding Shares
107,600,000
Free Float
96,405,000
Market Cap
$74.24 million
Optionable
Not Optionable
Beta
1.27
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSEAMERICAN:VNRX) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners